TW200613006A - Rebamipide preparation for rectal administration to be prepared before using - Google Patents

Rebamipide preparation for rectal administration to be prepared before using

Info

Publication number
TW200613006A
TW200613006A TW094130255A TW94130255A TW200613006A TW 200613006 A TW200613006 A TW 200613006A TW 094130255 A TW094130255 A TW 094130255A TW 94130255 A TW94130255 A TW 94130255A TW 200613006 A TW200613006 A TW 200613006A
Authority
TW
Taiwan
Prior art keywords
preparation
rebamipide
rectal administration
prepared before
solid particle
Prior art date
Application number
TW094130255A
Other languages
Chinese (zh)
Inventor
Hirofumi Doi
Shun-Ichiro Sumida
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW200613006A publication Critical patent/TW200613006A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Rebamipide preparation for rectal administration to be prepared before using, which is a solid particle preparation comprising rebamipide and carmellose sodium and having excellent dispersibility in an aqueous vehicle, and can be administered rectally in the form of enema dispersion preparation by dispersing the solid particle preparation in an aqueous vehicle when used. The present rebamipide preparation is in a solid particle form such as a powder or pulverized powder form or a fine granule or granule form, and hence, it has excellent storage stability.
TW094130255A 2004-09-10 2005-09-05 Rebamipide preparation for rectal administration to be prepared before using TW200613006A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004263638 2004-09-10

Publications (1)

Publication Number Publication Date
TW200613006A true TW200613006A (en) 2006-05-01

Family

ID=36036545

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094130255A TW200613006A (en) 2004-09-10 2005-09-05 Rebamipide preparation for rectal administration to be prepared before using

Country Status (2)

Country Link
TW (1) TW200613006A (en)
WO (1) WO2006028270A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
TWI415629B (en) 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof
CN105012267A (en) * 2015-08-19 2015-11-04 海南科进生物制药有限公司 Rebamipide tablet and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06157355A (en) * 1992-11-13 1994-06-03 Dai Ichi Seiyaku Co Ltd Granular preparation for mri
JP3927253B2 (en) * 1995-02-02 2007-06-06 中外製薬株式会社 Sucralfate formulation

Also Published As

Publication number Publication date
WO2006028270A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
MX2011012196A (en) Compositions and methods for drug delivery.
AP2003002819A0 (en) Pharmaceutical compositions comprising amlodipine maleate
WO2014022368A3 (en) Anti-reflective hard coat and anti-reflective article
MX336930B (en) Ganaxolone formulations and methods for the making and use thereof.
AU2013334740A8 (en) Stable, low viscosity antibody formulation
WO2007116954A3 (en) Inorganic nanoparticle comprising an active substance immobilized on the surface and a polymer
IN2015DN00888A (en)
DE602005025083D1 (en)
WO2008102746A1 (en) Carbon nanotube assembly and electrically conductive film
BR112015031906A2 (en) electrode material and its use in lithium ion batteries
WO2005104712A3 (en) Dpi formulation containing sulfoalkyl ether cyclodextrin
WO2009060803A1 (en) Copper fine particle, method for producing the same, and copper fine particle dispersion
WO2008011641A3 (en) A method of agglomeration
WO2008149788A1 (en) Solid dialysis preparation
TW200613006A (en) Rebamipide preparation for rectal administration to be prepared before using
AU2002357457A1 (en) Powder for nasal administration of drugs
WO2011134962A3 (en) Orally disintegrating tablet containing acarbose
TW200730170A (en) Micronised azodicarbonamide, and the preparation and use thereof
WO2011090724A3 (en) Gastroretentive solid oral dosage forms with lipid-based low-density excipient
AU2003900335A0 (en) Microparticles for selectively targeted hyperthermia
WO2011087705A3 (en) Fine particle croscarmellose and uses thereof
JP2013520393A5 (en)
MY121175A (en) Ciclesonide-containing aqueous pharmaceutical composition
WO2008108179A1 (en) Tin powder, tin paste and tin powder manufacturing method
EA200900464A1 (en) PHARMACEUTICAL COMPOSITION FOR INHALATION